Soft tissues connect and provide strength & support to organs of body. Soft tissues include synovial membrane, nervous tissue, cartilage, skin, ligaments, tendons, and muscles. The process of soft tissue repair commences from occurrence of injury and moves ahead toward its healing, which is divided into three steps – inflammation, tissue repair, remodeling.
Development of Technologically Advanced & Innovative Products to Drive the Soft Tissue Repair Market Growth
There has been a rise in awareness about possibility of skeletally immature patients to be affected from tear in their ligaments and connective tissue. People around the world are also being made aware about commercialization, promotion, and development of advanced plate-rich plasma devices, which can be used for musculoskeletal disorders. In addition, several technological innovations and advancements have been witnessed in the field of orthopedic connective tissue repair. Novel advancements, such as the innovative surgical techniques, have been observed in anterior cruciate ligament (ACL) reconstruction procedures for making them more efficient.
Companies such as NORAKER, and Zimmer Biomet have been making developments in bioabsorbable soft tissue screws. Leading players in the market have also been concentrating on developing mesh with biological product, working as a substitute for a human allograft. For example – EZ Derm, used as dressing for wound therapy, was developed by MoInlycke Health Care, where wire and pins are used in conjunction, or independently, with several other internal fixation devices such as meshes. These devices are used in spine and hip replacement surgeries. The aforementioned factors are expected to have a positive influence on expansion of the global soft tissue repair market.
The most common reasons for muscle damage are sports-related injuries. Athletes often are affected from ACL tear while playing the game, or performing other physical activities. Growing geriatric population also plays an important role in the market growth, as aging results into significant transformations in the neuromuscular, and skeletal systems, further resulting into arthritis, ACL tear, and weak ligaments. Obesity in aging population is discerned to directly increase possibility of degenerative bone disorders, including osteoporosis, and osteoarthritis. These factors will increase demand for soft tissue repair procedures.
However, factors such as high cost of procedures, unfavorable reimbursement policies, and lack of awareness among people in remote regions are expected to hinder growth of the market in the upcoming years. The global market for soft tissue repair is anticipated to register a healthy expansion, according to a recent research report by Future Market Insights (FMI), during the forecast period 2017 to 2022. Revenues from the market are expected to reach nearly US$ 15,500 Mn by 2022-end.
Request to view Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-4931
North America will Remain Dominant in the Market
North America is expected to be the dominant region in the global soft tissue repair market, in terms of revenues. This is mainly because of the rise in healthcare expenditure in the region. The market in North America is expected to account for approximately US$ 6,000 Mn revenues by 2022-end.
On the basis of application, breast reconstruction, and dental soft tissue repair are expected to register a parallel expansion at 5.5% CAGR through 2022. Demand for soft tissue repair procedures will remain relatively lower in dural repair application over the forecast period.
Clinics- Fastest Growing End-users in the Market
Clinics are estimated to be the fastest growing end-users in the global soft tissue repair market. Nearly one-fourth share of the market are expected to be accounted by clinics during 2017 to 2022. ASCs are expected to remain the least lucrative end-users of soft tissue repair procedures in the global market.
Allograft is expected to remain sought-after among products in the global soft tissue repair market, with sales projected to surpass US$ 5,000 Mn in revenues by 2022-end. Sales of allograft are expected to register the fastest expansion in the market through 2022.
FMI’s report has listed key players in the global soft tissue repair market, which include Arthrex Inc., Smith & Nephew, Zimmer Biomet Holdings, Inc., Stryker Corporation, DePuy Synthes, Braun Melsungen AG, C. R. Bard, Inc., CONMED Corporation, Medtronic Plc., Integra LifeScience Corporation, and Wright Medical Group N.V.